FBRX (Forte Biosciences, Inc.) חוב לטווח קצר להון
The market valuation for Forte Biosciences, Inc. (FBRX) displayed on GURU.Markets is 0.00. Forte Biosciences, Inc. (FBRX) is establishing authority in the therapy of autoimmune skin disorders by developing methods to combat eczema. Currently, Forte Biosciences, Inc. (FBRX) is rebuilding its image following an update to its medical programs, while interest in its software remains volatile. Growth prospects are based on the development of unique compounds that guarantee pricing power over its medications.
פילוחים אנליטיים של חברת Forte Biosciences, Inc.
The short-term debt-to-equity ratio measures the proportion of liabilities maturing within one year relative to the company's equity. Investors utilize this metric to assess liquidity and the issuer's ability to service urgent loans without impairing assets. Analyzing the historical trend of short-term debt to equity can reveal risks of financial instability. For Forte Biosciences, Inc. (FBRX), this is critical due to the lack of revenue and dependence on clinical trial outcomes.